Replies to post #445940 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

The other co-primary endpoint, the Clinical Global Impression – Improvement scale (CGI-I), which represents a less granular assessment by the site investigators using a seven-point scoring (one=“very much improved” to seven=“very much worse”), was not met.

https://www.anavex.com/post/anavex-life-sciences-provides-update-rett-syndrome-program